List of Tables
Table 1. Global Sirolimus Eluting Stent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Sirolimus Eluting Stent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Sirolimus Eluting Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Sirolimus Eluting Stent Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Sirolimus Eluting Stent Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Sirolimus Eluting Stent Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Sirolimus Eluting Stent Sales by Region (2020-2025) & (K Units)
Table 8. Global Sirolimus Eluting Stent Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Sirolimus Eluting Stent Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Sirolimus Eluting Stent Sales Share by Manufacturers (2020-2025)
Table 12. Global Sirolimus Eluting Stent Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Sirolimus Eluting Stent Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Sirolimus Eluting Stent by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sirolimus Eluting Stent as of 2024)
Table 16. Global Sirolimus Eluting Stent Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Sirolimus Eluting Stent Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Sirolimus Eluting Stent Manufacturing Base and Headquarters
Table 19. Global Sirolimus Eluting Stent Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Sirolimus Eluting Stent Sales by Type (2020-2025) & (K Units)
Table 23. Global Sirolimus Eluting Stent Sales by Type (2026-2031) & (K Units)
Table 24. Global Sirolimus Eluting Stent Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Sirolimus Eluting Stent Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Sirolimus Eluting Stent ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Sirolimus Eluting Stent Sales by Application (2020-2025) & (K Units)
Table 29. Global Sirolimus Eluting Stent Sales by Application (2026-2031) & (K Units)
Table 30. Sirolimus Eluting Stent High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Sirolimus Eluting Stent Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Sirolimus Eluting Stent Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Sirolimus Eluting Stent ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Sirolimus Eluting Stent Growth Accelerators and Market Barriers
Table 37. North America Sirolimus Eluting Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Sirolimus Eluting Stent Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Sirolimus Eluting Stent Growth Accelerators and Market Barriers
Table 40. Europe Sirolimus Eluting Stent Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Sirolimus Eluting Stent Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Sirolimus Eluting Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Sirolimus Eluting Stent Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Sirolimus Eluting Stent Growth Accelerators and Market Barriers
Table 45. Southeast Asia Sirolimus Eluting Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Sirolimus Eluting Stent Investment Opportunities and Key Challenges
Table 47. Central and South America Sirolimus Eluting Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Sirolimus Eluting Stent Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Sirolimus Eluting Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. QualiMe Corporation Information
Table 51. QualiMe Description and Major Businesses
Table 52. QualiMe Product Models, Descriptions and Specifications
Table 53. QualiMe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. QualiMe Sales Value Proportion by Product in 2024
Table 55. QualiMe Sales Value Proportion by Application in 2024
Table 56. QualiMe Sales Value Proportion by Geographic Area in 2024
Table 57. QualiMe Sirolimus Eluting Stent SWOT Analysis
Table 58. QualiMe Recent Developments
Table 59. Cardionovum Corporation Information
Table 60. Cardionovum Description and Major Businesses
Table 61. Cardionovum Product Models, Descriptions and Specifications
Table 62. Cardionovum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Cardionovum Sales Value Proportion by Product in 2024
Table 64. Cardionovum Sales Value Proportion by Application in 2024
Table 65. Cardionovum Sales Value Proportion by Geographic Area in 2024
Table 66. Cardionovum Sirolimus Eluting Stent SWOT Analysis
Table 67. Cardionovum Recent Developments
Table 68. MicroPort Corporation Information
Table 69. MicroPort Description and Major Businesses
Table 70. MicroPort Product Models, Descriptions and Specifications
Table 71. MicroPort Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. MicroPort Sales Value Proportion by Product in 2024
Table 73. MicroPort Sales Value Proportion by Application in 2024
Table 74. MicroPort Sales Value Proportion by Geographic Area in 2024
Table 75. MicroPort Sirolimus Eluting Stent SWOT Analysis
Table 76. MicroPort Recent Developments
Table 77. B. Braun Corporation Information
Table 78. B. Braun Description and Major Businesses
Table 79. B. Braun Product Models, Descriptions and Specifications
Table 80. B. Braun Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. B. Braun Sales Value Proportion by Product in 2024
Table 82. B. Braun Sales Value Proportion by Application in 2024
Table 83. B. Braun Sales Value Proportion by Geographic Area in 2024
Table 84. B. Braun Sirolimus Eluting Stent SWOT Analysis
Table 85. B. Braun Recent Developments
Table 86. P+F Products + Features GmbH Corporation Information
Table 87. P+F Products + Features GmbH Description and Major Businesses
Table 88. P+F Products + Features GmbH Product Models, Descriptions and Specifications
Table 89. P+F Products + Features GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. P+F Products + Features GmbH Sales Value Proportion by Product in 2024
Table 91. P+F Products + Features GmbH Sales Value Proportion by Application in 2024
Table 92. P+F Products + Features GmbH Sales Value Proportion by Geographic Area in 2024
Table 93. P+F Products + Features GmbH Sirolimus Eluting Stent SWOT Analysis
Table 94. P+F Products + Features GmbH Recent Developments
Table 95. Terumo Corporation Information
Table 96. Terumo Description and Major Businesses
Table 97. Terumo Product Models, Descriptions and Specifications
Table 98. Terumo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Terumo Recent Developments
Table 100. Biotronik Corporation Information
Table 101. Biotronik Description and Major Businesses
Table 102. Biotronik Product Models, Descriptions and Specifications
Table 103. Biotronik Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Biotronik Recent Developments
Table 105. USM Healthcare Corporation Information
Table 106. USM Healthcare Description and Major Businesses
Table 107. USM Healthcare Product Models, Descriptions and Specifications
Table 108. USM Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. USM Healthcare Recent Developments
Table 110. Concept Medical Inc Corporation Information
Table 111. Concept Medical Inc Description and Major Businesses
Table 112. Concept Medical Inc Product Models, Descriptions and Specifications
Table 113. Concept Medical Inc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Concept Medical Inc Recent Developments
Table 115. MicroPort Scientific Corporation Corporation Information
Table 116. MicroPort Scientific Corporation Description and Major Businesses
Table 117. MicroPort Scientific Corporation Product Models, Descriptions and Specifications
Table 118. MicroPort Scientific Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. MicroPort Scientific Corporation Recent Developments
Table 120. Lepu Medical Technology Corporation Information
Table 121. Lepu Medical Technology Description and Major Businesses
Table 122. Lepu Medical Technology Product Models, Descriptions and Specifications
Table 123. Lepu Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Lepu Medical Technology Recent Developments
Table 125. JW Medical Systems Corporation Information
Table 126. JW Medical Systems Description and Major Businesses
Table 127. JW Medical Systems Product Models, Descriptions and Specifications
Table 128. JW Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. JW Medical Systems Recent Developments
Table 130. SINOMED Corporation Information
Table 131. SINOMED Description and Major Businesses
Table 132. SINOMED Product Models, Descriptions and Specifications
Table 133. SINOMED Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. SINOMED Recent Developments
Table 135. Kinhely Bio-Tech Corporation Information
Table 136. Kinhely Bio-Tech Description and Major Businesses
Table 137. Kinhely Bio-Tech Product Models, Descriptions and Specifications
Table 138. Kinhely Bio-Tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Kinhely Bio-Tech Recent Developments
Table 140. Shandong Huaan Biotechnology Corporation Information
Table 141. Shandong Huaan Biotechnology Description and Major Businesses
Table 142. Shandong Huaan Biotechnology Product Models, Descriptions and Specifications
Table 143. Shandong Huaan Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Shandong Huaan Biotechnology Recent Developments
Table 145. Blue Sail Medical Corporation Information
Table 146. Blue Sail Medical Description and Major Businesses
Table 147. Blue Sail Medical Product Models, Descriptions and Specifications
Table 148. Blue Sail Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Blue Sail Medical Recent Developments
Table 150. Shanghai Bio-heart Biological Technology Corporation Information
Table 151. Shanghai Bio-heart Biological Technology Description and Major Businesses
Table 152. Shanghai Bio-heart Biological Technology Product Models, Descriptions and Specifications
Table 153. Shanghai Bio-heart Biological Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Shanghai Bio-heart Biological Technology Recent Developments
Table 155. Key Raw Materials Distribution
Table 156. Raw Materials Key Suppliers
Table 157. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 158. Milestones in Production Technology Evolution
Table 159. Distributors List
Table 160. Market Trends and Market Evolution
Table 161. Market Drivers and Opportunities
Table 162. Market Challenges, Risks, and Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Sirolimus Eluting Stent Product Picture
Figure 2. Global Sirolimus Eluting Stent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Cobalt Chromium Alloy Material Product Picture
Figure 4. Stainless Steel Material Product Picture
Figure 5. Others Product Picture
Figure 6. Global Sirolimus Eluting Stent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Sirolimus Eluting Stent Report Years Considered
Figure 11. Global Sirolimus Eluting Stent Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 13. Global Sirolimus Eluting Stent Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Sirolimus Eluting Stent Revenue Market Share by Region (2020-2031)
Figure 15. Global Sirolimus Eluting Stent Sales (2020-2031) & (K Units)
Figure 16. Global Sirolimus Eluting Stent Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Sirolimus Eluting Stent Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Sirolimus Eluting Stent Sales Volume Market Share in 2024
Figure 19. Global Sirolimus Eluting Stent Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Cobalt Chromium Alloy Material Revenue Market Share by Manufacturer in 2024
Figure 22. Stainless Steel Material Revenue Market Share by Manufacturer in 2024
Figure 23. Others Revenue Market Share by Manufacturer in 2024
Figure 24. Global Sirolimus Eluting Stent Sales Market Share by Type (2020-2031)
Figure 25. Global Sirolimus Eluting Stent Revenue Market Share by Type (2020-2031)
Figure 26. Global Sirolimus Eluting Stent Sales Market Share by Application (2020-2031)
Figure 27. Global Sirolimus Eluting Stent Revenue Market Share by Application (2020-2031)
Figure 28. North America Sirolimus Eluting Stent Sales YoY (2020-2031) & (K Units)
Figure 29. North America Sirolimus Eluting Stent Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Sirolimus Eluting Stent Sales Revenue (US$ Million) in 2024
Figure 31. North America Sirolimus Eluting Stent Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Sirolimus Eluting Stent Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Sirolimus Eluting Stent Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Sirolimus Eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Sirolimus Eluting Stent Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Sirolimus Eluting Stent Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Sirolimus Eluting Stent Sales Revenue (US$ Million) in 2024
Figure 41. Europe Sirolimus Eluting Stent Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Sirolimus Eluting Stent Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Sirolimus Eluting Stent Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Sirolimus Eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 46. France Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Sirolimus Eluting Stent Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Sirolimus Eluting Stent Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Sirolimus Eluting Stent Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Sirolimus Eluting Stent Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Sirolimus Eluting Stent Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Sirolimus Eluting Stent Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Sirolimus Eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 61. India Sirolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Sirolimus Eluting Stent Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Sirolimus Eluting Stent Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Sirolimus Eluting Stent Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Sirolimus Eluting Stent Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Sirolimus Eluting Stent Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Sirolimus Eluting Stent Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Sirolimus Eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Sirolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Sirolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Sirolimus Eluting Stent Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Sirolimus Eluting Stent Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Sirolimus Eluting Stent Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Sirolimus Eluting Stent Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Sirolimus Eluting Stent Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Sirolimus Eluting Stent Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Sirolimus Eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Sirolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Sirolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Sirolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Sirolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
Figure 82. Sirolimus Eluting Stent Industry Chain Mapping
Figure 83. Regional Sirolimus Eluting Stent Manufacturing Base Distribution (%)
Figure 84. Global Sirolimus Eluting Stent Production Market Share by Region (2020-2031)
Figure 85. Sirolimus Eluting Stent Production Process
Figure 86. Regional Sirolimus Eluting Stent Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
